Bio-Techne Corp
(TECH)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 06/30
| 12-2020 | 09-2020 | 06-2020 | 03-2020 | 12-2019 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 79,538 | 33,395 | 229,296 | 170,451 | 134,018 |
| Depreciation Amortization | 41,972 | 21,088 | 82,737 | 61,746 | 40,638 |
| Income taxes - deferred | 216 | -452 | 13,130 | 8,641 | 14,805 |
| Accounts receivable | -2,327 | 910 | 6,556 | 2,692 | 9,950 |
| Accounts payable and accrued liabilities | 8,624 | 6,918 | 10,343 | 10,031 | 7,115 |
| Other Working Capital | 6,472 | -5,371 | -5,246 | 5,784 | 13,565 |
| Other Operating Activity | 20,783 | 9,521 | -131,599 | -98,919 | -109,134 |
| Operating Cash Flow | $155,278 | $66,009 | $205,217 | $160,426 | $110,957 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 15,962 | 2,800 | 76,933 | 71,939 | 43,299 |
| PPE Investments | -22,383 | -10,938 | -51,744 | -34,371 | -25,089 |
| Net Acquisitions | -9,765 | N/A | N/A | N/A | N/A |
| Purchase Of Investment | N/A | N/A | 1,906 | N/A | N/A |
| Other Investing Activity | -556 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $-16,742 | $-8,138 | $27,095 | $37,568 | $18,210 |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | 40,000 | N/A | N/A |
| Debt Issued | N/A | N/A | N/A | 40,000 | N/A |
| Debt Repayment | -125,250 | -33,125 | N/A | -125,375 | -122,250 |
| Common Stock Issued | 32,337 | 15,418 | 70,983 | 38,490 | 27,247 |
| Common Stock Repurchased | N/A | N/A | -50,112 | -50,112 | N/A |
| Dividend Paid | -24,728 | -12,336 | -48,902 | -36,644 | -24,365 |
| Other Financing Activity | -7,371 | -4,890 | -195,771 | -5,441 | -1,928 |
| Financing Cash Flow | $-125,012 | $-34,933 | $-183,802 | $-139,082 | $-121,296 |
| Exchange Rate Effect | 5,377 | -159 | -2,771 | -3,582 | 1,535 |
| Beginning Cash Position | 146,625 | 146,625 | 100,886 | 100,886 | 100,886 |
| End Cash Position | 165,526 | 169,404 | 146,625 | 156,216 | 110,293 |
| Net Cash Flow | $18,901 | $22,779 | $45,739 | $55,330 | $9,406 |
| Free Cash Flow | |||||
| Operating Cash Flow | 155,278 | 66,009 | 205,217 | 160,426 | 110,957 |
| Capital Expenditure | -22,383 | -10,938 | -51,744 | -34,371 | -25,089 |
| Free Cash Flow | 132,895 | 55,071 | 153,473 | 126,055 | 85,868 |